Overview
Diagnosis and Therapy
Disorders and Conditions
Status
Recruiting
Start/End Dates
Locations
St. Paul's Hospital
Vancouver General Hospital
Name/Title
Gale Ladua, Research Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to assess COVID-19 prophylactic/therapeutic safety and effectiveness in transplant patients, assess mental health impacts of COVID-19 on transplant patients and families, develop strategies to improve well-being, and determine the economic burden and value of emerging and existing prophylactic/therapeutic options for COVID-19 in transplant patients.
Eligibility
This study is open to adults age 19 and over. Participants must be: solid organ transplant recipient being followed in person or remotely at Vancouver General Hospital (VGH) or St. Paul's Hospital (SPH); allogeneic bone marrow transplant recipient being followed at VGH; or autologous bone marrow transplant recipient within 12 months of transplant date being followed at VGH. Family and caregivers associated with the patient followed at VGH or SPH are also eligible to participate.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
The purpose of this study is to assess COVID-19 prophylactic/therapeutic safety and effectiveness in transplant patients, assess mental health impacts of COVID-19 on transplant patients and families, develop strategies to improve well-being, and determine the economic burden and value of emerging and existing prophylactic/therapeutic options for COVID-19 in transplant patients.
This study is open to adults age 19 and over. Participants must be: solid organ transplant recipient being followed in person or remotely at Vancouver General Hospital (VGH) or St. Paul's Hospital (SPH); allogeneic bone marrow transplant recipient being followed at VGH; or autologous bone marrow transplant recipient within 12 months of transplant date being followed at VGH. Family and caregivers associated with the patient followed at VGH or SPH are also eligible to participate.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
